Browse CATs

Browse CATs  internal medicine  cardiology  congestive heart failure

Diagnosis Economics Harm/ aetiology Prognosis Therapy

Arrhythmias amiodarone caused pulmonary toxicity. Level of evidence 4 Expiry Date November 2003 Atrial fibrillation increased risk with heart failure, hypertension and valvular heart disease. Level of evidence 1b Expiry Date November 2003 COPD acute exacerbation caused by heart failure decreased risk of dying. Level of evidence 1b Expiry Date November 2003 Cardiac arrest a previous stroke, renal failure and current congestive heart failure increased the risk of dying following an arrest Level of evidence 1b Expiry Date October 2003 Cardiac arrest increasing age, in-hospital arrest, long CPR time, long total arrest time, history of diabetes or congestive heart failure, or noncardiac arrest increased the risk of dying. Level of evidence 2b Expiry Date October 2003 Heart failure syncope increased the risk of dying in severe cases. Level of evidence 2b Expiry Date July 2003 Heart failure arterial thromboembolic events are uncommon Level of evidence 2a Expiry Date October 2003 Heart failure acute pulmonary oedema: first attack and dopamine use increased the risk of dying Level of evidence 1b Expiry Date October 2003 Heart failure ejection fraction, functional class, non ischaemic heart disease and frequency of ventricular fibrillation increase risk of death. Level of evidence 1b Expiry Date October 2003 Heart failure a previous hospitalization with pulmonary edema hospitalisation with pulmonary oedema increased the risk of dying in-hospital. Level of evidence 2b Expiry Date October 2003 Heart failure abnormality in diastolic function was quite common. Level of evidence 3b Expiry Date October 2003 Heart failure a poor or worsening ejection fraction helped predict mortality Level of evidence 2b Expiry Date October 2003 Heart failure severe heart failure, reduced ejection fraction, atrial fibrillation, stroke and diabetes increased the risk of death. Level of evidence 2b Expiry Date October 2003 Heart failure reduced activity and general health increased the risk of dying or being hospitalised Level of evidence 2b Expiry Date October 2003 Heart failure an enlarged heart and reduced heart rate variability helped predict death Level of evidence 1b Expiry Date October 2003 Heart failure nonsustained ventricular tachycardia increased the risk of death. Level of evidence 1b Expiry Date October 2003 Heart failure advanced age and moderate or severe functional class increased the risk of death within 5 years. Level of evidence 2b Expiry Date November 2003 Heart failure older age and a lower ejection fraction increased risk of dying. Level of evidence 2b Expiry Date October 2003 Heart failure female sex reduced the risk of dying in severe disease Level of evidence 2b Expiry Date November 2003 Myocardial infarction inferior: complete heart block and heart failure increased the risk of dying. Level of evidence 1b Expiry Date October 2003 Myocardial infarction Killip class measured severity of heart failure. Level of evidence 4 Expiry Date February 2003 Myocardial infarction LV dysfunction: mitral regurgitation, hypertension and worsening ejection fraction increased the risk of dying. Level of evidence 2b Expiry Date February 2003 Myocardial infarction worsening Killip class and increasing age increased the risk of dying. Level of evidence 1b Expiry Date February 2003 Myocardial infarction echocardiographic features after 6 weeks helped predict death and heart failure. Level of evidence 2b Expiry Date October 2003